Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect

Changes in Brain Function during Administration of Venlafaxine or Placebo to Normal Subjects

(2012) Andrew F. Leuchter et al.   CLINICAL EEG AND NEUROSCIENCE

Use of Clinical Neurophysiology for the Selection of Medication in the Treatment of Major Depressive Disorder: The State of the Evidence

(2012) Andrew F. Leuchter et al.   CLINICAL EEG AND NEUROSCIENCE

Glutamate and the Neural Basis of the Subjective Effects of Ketamine

(2008) J. F. William Deakin et al.   ARCHIVES OF GENERAL PSYCHIATRY

Increased Anterior Cingulate Cortical Activity in Response to Fearful Faces: A Neurophysiological Biomarker that Predicts Rapid Antidepressant Response to Ketamine

(2008) Giacomo Salvadore et al.   BIOLOGICAL PSYCHIATRY

Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder

(2008) Martin Bares et al.   EUROPEAN PSYCHIATRY

Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of Mania

(2008) Steven T. Szabo et al.   NEUROPHARMACOLOGY

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors

(2008) Věra Bubeníková-Valešová et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

(2007) Sungho Maeng et al.   BIOLOGICAL PSYCHIATRY